Reference priceCNY ¥630.00Original source price: INR 52,500.00. Converted estimates are available by currency selection.
| Brand | Sclerosol Intrapleural Aerosol |
|---|---|
| Manufacturer | Bryan Corporation |
| Prescription required | Yes |
Sclerosol Intrapleural Aerosol kit 4g/25g (sterile talc powder)
sterile talc powder
Description
Sclerosol Intrapleural Aerosol kit 4g/25g (sterile talc powder) is a medicine catalog record in the MediPriceHub database. Active ingredient: sterile talc powder. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: Bryan Corporation. Therapeutic category: Medicine Library > Oncology Medicines > Malignant pleural effusion. Pack information: 4 / 25. Origin country or market: United States. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
Sclerosol® Intrapleural Aerosol, administered by aerosol during thoracoscopy or open thoracotomy, is indicated to prevent recurrence of malignant pleural effusions in symptomatic patients.How to Use
Company:Bryan Corporation Treatment for:malignant pleural effusions Adult Dosing & Uses Dosing Forms & Strengths intrapleural aerosol sclerosing powder 5g/100mL bottle Malignant Pleural Effusion Indicated as a sclerosing agent to decrease malignant pleural effusion recurrence in symptomatic patients Administered intrapleurally via chest tube after adequate drainage of the effusion Sclerosol:4-8g(1-2canisters); deliver by manually pressing actuator button; distal end of the delivery tube should be pointed in several different directions, while short bursts are administered to distribute talc powder equally and extensively on all visceral and parietal pleural surfaces General Information Sclerosol Intrapleural Aerosol has been approved for the prevention of recurrence of malignant pleural effusions in symptomatic patients. Symptoms include chest pain, dyspnea, and coughing.It is to be administered by aerosol during thracoscopy or open thoracotomy.Specification
Active ingredient: sterile talc powder. Pack size: 4 / 25. Pack unit: unit. Manufacturer: Bryan Corporation. Origin country: United States. Source category: Medicine Library > Oncology Medicines > Malignant pleural effusion. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
Cancer medicines may cause fatigue, nausea, vomiting, diarrhea or constipation, appetite changes, mouth sores, rash, changes in blood counts, infection risk, liver or kidney test changes, bleeding risk, neuropathy, infusion reactions, or organ-specific toxicity depending on the medicine. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, confusion, serious bleeding, signs of infection, or rapidly worsening symptoms. The approved local prescribing information is the controlling source for the complete adverse-reaction profile.以上内容仅供参考。使用药品前请咨询合格的医疗专业人士。